The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-12-08

AUTHORS

Małgorzata Mikulska, Thierry Calandra, Maurizio Sanguinetti, Daniel Poulain, Claudio Viscoli, the Third European Conference on Infections in Leukemia Group

ABSTRACT

IntroductionTimely diagnosis of invasive candidiasis (IC) remains difficult as the clinical presentation is not specific and blood cultures lack sensitivity and need a long incubation time. Thus, non-culture-based methods for diagnosing IC have been developed. Mannan antigen (Mn) and anti-mannan antibodies (A-Mn) are present in patients with IC. On behalf of the Third European Conference on Infections in Leukemia, the performance of these tests was analysed and reviewed.MethodsThe literature was searched for studies using the commercially available sandwich enzyme-linked immunosorbent assays (Platelia™, Bio-Rad Laboratories, Marnes-la-Coquette, France) for detecting Mn and A-Mn in serum. The target condition of this review was IC defined according to 2008 European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. Sensitivity, specificity and diagnostic odds ratios (DOR) were calculated for Mn, A-Mn and combined Mn/A-Mn testing.ResultsOverall, 14 studies that comprised 453 patients and 767 controls were reviewed. The patient populations included in the studies were mainly haematological and cancer cases in seven studies and mainly intensive care unit and surgery cases in the other seven studies. All studies but one were retrospective in design. Mn sensitivity was 58% (95% confidence interval [CI], 53-62); specificity, 93% (95% CI, 91-94) and DOR, 18 (95% CI 12-28). A-Mn sensitivity was 59% (95% CI, 54-65); specificity, 83% (95% CI, 79-97) and DOR, 12 (95% CI 7-21). Combined Mn/A-Mn sensitivity was 83% (95% CI, 79-87); specificity, 86% (95% CI, 82-90) and DOR, 58 (95% CI 27-122). Significant heterogeneity of the studies was detected. The sensitivity of both Mn and A-Mn varied for different Candida species, and it was the highest for C. albicans, followed by C. glabrata and C. tropicalis. In 73% of 45 patients with candidemia, at least one of the serological tests was positive before the culture results, with mean time advantage being 6 days for Mn and 7 days for A-Mn. In 21 patients with hepatosplenic IC, 18 (86%) had Mn or A-Mn positive test results at a median of 16 days before radiological detection of liver or spleen lesions.ConclusionsMn and A-Mn are useful for diagnosis of IC. The performance of combined Mn/A-Mn testing is superior to either Mn or A-Mn testing. More... »

PAGES

r222

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/cc9365

DOI

http://dx.doi.org/10.1186/cc9365

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035798140

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21143834


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Fungal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Fungal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Candida", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Candidiasis, Invasive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Congresses as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Europe", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mannans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.410345.7", 
          "name": [
            "Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mikulska", 
        "givenName": "Ma\u0142gorzata", 
        "id": "sg:person.01272344176.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272344176.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.9851.5", 
          "name": [
            "Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Calandra", 
        "givenName": "Thierry", 
        "id": "sg:person.01103701061.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103701061.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Cattolica del S. Cuore, Institute Of Microbiology, Largo F. Vito 1, 00168, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.8142.f", 
          "name": [
            "Universit\u00e0 Cattolica del S. Cuore, Institute Of Microbiology, Largo F. Vito 1, 00168, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sanguinetti", 
        "givenName": "Maurizio", 
        "id": "sg:person.0775516471.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775516471.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 Inserm U799, Facult\u00e9 de M\u00e9decine, P\u00f4le Recherche, Place Verdun, F-59045, Lille, cedex, France", 
          "id": "http://www.grid.ac/institutes/grid.7429.8", 
          "name": [
            "Unit\u00e9 Inserm U799, Facult\u00e9 de M\u00e9decine, P\u00f4le Recherche, Place Verdun, F-59045, Lille, cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Poulain", 
        "givenName": "Daniel", 
        "id": "sg:person.01035744051.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035744051.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa, Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "University of Genoa, Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Viscoli", 
        "givenName": "Claudio", 
        "id": "sg:person.01241060757.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241060757.05"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "the Third European Conference on Infections in Leukemia Group", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2334-7-103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015191232", 
          "https://doi.org/10.1186/1471-2334-7-103"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-007-0373-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017843109", 
          "https://doi.org/10.1007/s10096-007-0373-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s100960100629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011904460", 
          "https://doi.org/10.1007/s100960100629"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-12-08", 
    "datePublishedReg": "2010-12-08", 
    "description": "IntroductionTimely diagnosis of invasive candidiasis (IC) remains difficult as the clinical presentation is not specific and blood cultures lack sensitivity and need a long incubation time. Thus, non-culture-based methods for diagnosing IC have been developed. Mannan antigen (Mn) and anti-mannan antibodies (A-Mn) are present in patients with IC. On behalf of the Third European Conference on Infections in Leukemia, the performance of these tests was analysed and reviewed.MethodsThe literature was searched for studies using the commercially available sandwich enzyme-linked immunosorbent assays (Platelia\u2122, Bio-Rad Laboratories, Marnes-la-Coquette, France) for detecting Mn and A-Mn in serum. The target condition of this review was IC defined according to 2008 European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. Sensitivity, specificity and diagnostic odds ratios (DOR) were calculated for Mn, A-Mn and combined Mn/A-Mn testing.ResultsOverall, 14 studies that comprised 453 patients and 767 controls were reviewed. The patient populations included in the studies were mainly haematological and cancer cases in seven studies and mainly intensive care unit and surgery cases in the other seven studies. All studies but one were retrospective in design. Mn sensitivity was 58% (95% confidence interval [CI], 53-62); specificity, 93% (95% CI, 91-94) and DOR, 18 (95% CI 12-28). A-Mn sensitivity was 59% (95% CI, 54-65); specificity, 83% (95% CI, 79-97) and DOR, 12 (95% CI 7-21). Combined Mn/A-Mn sensitivity was 83% (95% CI, 79-87); specificity, 86% (95% CI, 82-90) and DOR, 58 (95% CI 27-122). Significant heterogeneity of the studies was detected. The sensitivity of both Mn and A-Mn varied for different Candida species, and it was the highest for C. albicans, followed by C. glabrata and C. tropicalis. In 73% of 45 patients with candidemia, at least one of the serological tests was positive before the culture results, with mean time advantage being 6 days for Mn and 7 days for A-Mn. In 21 patients with hepatosplenic IC, 18 (86%) had Mn or A-Mn positive test results at a median of 16 days before radiological detection of liver or spleen lesions.ConclusionsMn and A-Mn are useful for diagnosis of IC. The performance of combined Mn/A-Mn testing is superior to either Mn or A-Mn testing.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/cc9365", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1117766", 
        "issn": [
          "1364-8535", 
          "1466-609X"
        ], 
        "name": "Critical Care", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "anti-mannan antibodies", 
      "invasive candidiasis", 
      "diagnostic odds ratio", 
      "mannan antigen", 
      "available sandwich enzyme-linked immunosorbent assay", 
      "Cancer/Mycoses Study Group criteria", 
      "Mycoses Study Group criteria", 
      "diagnosis of IC", 
      "Study Group criteria", 
      "intensive care unit", 
      "Third European Conference", 
      "positive test results", 
      "enzyme-linked immunosorbent assay", 
      "sandwich enzyme-linked immunosorbent assay", 
      "spleen lesions", 
      "clinical presentation", 
      "care unit", 
      "patient population", 
      "Group criteria", 
      "odds ratio", 
      "surgery cases", 
      "cancer cases", 
      "radiological detection", 
      "different Candida species", 
      "patients", 
      "serological tests", 
      "European Organization", 
      "culture results", 
      "MethodsThe literature", 
      "immunosorbent assay", 
      "Candida species", 
      "diagnosis", 
      "significant heterogeneity", 
      "lack sensitivity", 
      "C. glabrata", 
      "candidiasis", 
      "leukemia", 
      "infection", 
      "antigen", 
      "C. tropicalis", 
      "antibodies", 
      "days", 
      "C. albicans", 
      "specificity", 
      "candidemia", 
      "ResultsOverall", 
      "target conditions", 
      "lesions", 
      "study", 
      "liver", 
      "testing", 
      "longer incubation times", 
      "serum", 
      "sensitivity", 
      "median", 
      "treatment", 
      "cases", 
      "presentation", 
      "glabrata", 
      "test", 
      "assays", 
      "incubation time", 
      "review", 
      "European Conference", 
      "population", 
      "albicans", 
      "tropicalis", 
      "recommendations", 
      "criteria", 
      "control", 
      "test results", 
      "heterogeneity", 
      "results", 
      "time advantage", 
      "use", 
      "conference", 
      "literature", 
      "detection", 
      "units", 
      "ratio", 
      "time", 
      "research", 
      "conditions", 
      "method", 
      "organization", 
      "behalf", 
      "advantages", 
      "design", 
      "species", 
      "performance", 
      "Mn"
    ], 
    "name": "The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia", 
    "pagination": "r222", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035798140"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/cc9365"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21143834"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/cc9365", 
      "https://app.dimensions.ai/details/publication/pub.1035798140"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_528.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/cc9365"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/cc9365'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/cc9365'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/cc9365'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/cc9365'


 

This table displays all metadata directly associated to this object as RDF triples.

256 TRIPLES      21 PREDICATES      131 URIs      120 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/cc9365 schema:about N1bb98c7f1dfd41cd856cd4dc6e036c0e
2 N2bbf1fb72de94a76b8f438d3bbb3f554
3 N5b5f19c3658345f0a0fd433458208aad
4 N5cc9b329431c430b9246acf00558628e
5 N7d991cddd82b4fb7ad22eeac7552b171
6 Nb207b0b52d34458c93b4d73cd0be9099
7 Nc108ece2060148f296e3f7c03ede55ee
8 Nc8b9f5de8d5849a6ab47b4e418d122ee
9 Nde32ebbb4e1940f8a86441ec1ef82f78
10 Nea60d65578ea47738a3a00a96b4afea1
11 Nf227e0f896c34c32972904c6817b3e86
12 Nffc6728de73f4aef95ca9928f58b5106
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Ndfe574577b8e450b8d9f21376cbb0530
16 schema:citation sg:pub.10.1007/s10096-007-0373-6
17 sg:pub.10.1007/s100960100629
18 sg:pub.10.1186/1471-2334-7-103
19 schema:datePublished 2010-12-08
20 schema:datePublishedReg 2010-12-08
21 schema:description IntroductionTimely diagnosis of invasive candidiasis (IC) remains difficult as the clinical presentation is not specific and blood cultures lack sensitivity and need a long incubation time. Thus, non-culture-based methods for diagnosing IC have been developed. Mannan antigen (Mn) and anti-mannan antibodies (A-Mn) are present in patients with IC. On behalf of the Third European Conference on Infections in Leukemia, the performance of these tests was analysed and reviewed.MethodsThe literature was searched for studies using the commercially available sandwich enzyme-linked immunosorbent assays (Platelia™, Bio-Rad Laboratories, Marnes-la-Coquette, France) for detecting Mn and A-Mn in serum. The target condition of this review was IC defined according to 2008 European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. Sensitivity, specificity and diagnostic odds ratios (DOR) were calculated for Mn, A-Mn and combined Mn/A-Mn testing.ResultsOverall, 14 studies that comprised 453 patients and 767 controls were reviewed. The patient populations included in the studies were mainly haematological and cancer cases in seven studies and mainly intensive care unit and surgery cases in the other seven studies. All studies but one were retrospective in design. Mn sensitivity was 58% (95% confidence interval [CI], 53-62); specificity, 93% (95% CI, 91-94) and DOR, 18 (95% CI 12-28). A-Mn sensitivity was 59% (95% CI, 54-65); specificity, 83% (95% CI, 79-97) and DOR, 12 (95% CI 7-21). Combined Mn/A-Mn sensitivity was 83% (95% CI, 79-87); specificity, 86% (95% CI, 82-90) and DOR, 58 (95% CI 27-122). Significant heterogeneity of the studies was detected. The sensitivity of both Mn and A-Mn varied for different Candida species, and it was the highest for C. albicans, followed by C. glabrata and C. tropicalis. In 73% of 45 patients with candidemia, at least one of the serological tests was positive before the culture results, with mean time advantage being 6 days for Mn and 7 days for A-Mn. In 21 patients with hepatosplenic IC, 18 (86%) had Mn or A-Mn positive test results at a median of 16 days before radiological detection of liver or spleen lesions.ConclusionsMn and A-Mn are useful for diagnosis of IC. The performance of combined Mn/A-Mn testing is superior to either Mn or A-Mn testing.
22 schema:genre article
23 schema:isAccessibleForFree true
24 schema:isPartOf N52499160d2de41d39b651cf1c8d7d40e
25 N874b982daf8c493f9b2861e9bc0a9d58
26 sg:journal.1117766
27 schema:keywords C. albicans
28 C. glabrata
29 C. tropicalis
30 Cancer/Mycoses Study Group criteria
31 Candida species
32 European Conference
33 European Organization
34 Group criteria
35 MethodsThe literature
36 Mn
37 Mycoses Study Group criteria
38 ResultsOverall
39 Study Group criteria
40 Third European Conference
41 advantages
42 albicans
43 anti-mannan antibodies
44 antibodies
45 antigen
46 assays
47 available sandwich enzyme-linked immunosorbent assay
48 behalf
49 cancer cases
50 candidemia
51 candidiasis
52 care unit
53 cases
54 clinical presentation
55 conditions
56 conference
57 control
58 criteria
59 culture results
60 days
61 design
62 detection
63 diagnosis
64 diagnosis of IC
65 diagnostic odds ratio
66 different Candida species
67 enzyme-linked immunosorbent assay
68 glabrata
69 heterogeneity
70 immunosorbent assay
71 incubation time
72 infection
73 intensive care unit
74 invasive candidiasis
75 lack sensitivity
76 lesions
77 leukemia
78 literature
79 liver
80 longer incubation times
81 mannan antigen
82 median
83 method
84 odds ratio
85 organization
86 patient population
87 patients
88 performance
89 population
90 positive test results
91 presentation
92 radiological detection
93 ratio
94 recommendations
95 research
96 results
97 review
98 sandwich enzyme-linked immunosorbent assay
99 sensitivity
100 serological tests
101 serum
102 significant heterogeneity
103 species
104 specificity
105 spleen lesions
106 study
107 surgery cases
108 target conditions
109 test
110 test results
111 testing
112 time
113 time advantage
114 treatment
115 tropicalis
116 units
117 use
118 schema:name The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia
119 schema:pagination r222
120 schema:productId N10c7117242524123bfafb4e74e06670e
121 N4b9f5c8927a84e958b33272fb18b6f3d
122 Nd877798e291e46bfb3524f1b5a424801
123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035798140
124 https://doi.org/10.1186/cc9365
125 schema:sdDatePublished 2022-10-01T06:36
126 schema:sdLicense https://scigraph.springernature.com/explorer/license/
127 schema:sdPublisher Na566f43bcbe340eba4ddea4421da9361
128 schema:url https://doi.org/10.1186/cc9365
129 sgo:license sg:explorer/license/
130 sgo:sdDataset articles
131 rdf:type schema:ScholarlyArticle
132 N10c7117242524123bfafb4e74e06670e schema:name dimensions_id
133 schema:value pub.1035798140
134 rdf:type schema:PropertyValue
135 N1bb98c7f1dfd41cd856cd4dc6e036c0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Humans
137 rdf:type schema:DefinedTerm
138 N1d51fa3ac9bc45689091739aaa48db0c rdf:first sg:person.01035744051.24
139 rdf:rest N66240ddc1a5e4926af50de9215d948c3
140 N2aa17f0b25ef47a397a9d3016938f6c1 rdf:first sg:person.01103701061.44
141 rdf:rest N9641e29b68b04b7e843d48ec6e2ee541
142 N2bbf1fb72de94a76b8f438d3bbb3f554 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Randomized Controlled Trials as Topic
144 rdf:type schema:DefinedTerm
145 N4b9f5c8927a84e958b33272fb18b6f3d schema:name doi
146 schema:value 10.1186/cc9365
147 rdf:type schema:PropertyValue
148 N52499160d2de41d39b651cf1c8d7d40e schema:volumeNumber 14
149 rdf:type schema:PublicationVolume
150 N5b5f19c3658345f0a0fd433458208aad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Europe
152 rdf:type schema:DefinedTerm
153 N5cc9b329431c430b9246acf00558628e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Congresses as Topic
155 rdf:type schema:DefinedTerm
156 N66240ddc1a5e4926af50de9215d948c3 rdf:first sg:person.01241060757.05
157 rdf:rest N9cfb19bc87964c2eb1a9776aeff57d08
158 N7d991cddd82b4fb7ad22eeac7552b171 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Candida
160 rdf:type schema:DefinedTerm
161 N874b982daf8c493f9b2861e9bc0a9d58 schema:issueNumber 6
162 rdf:type schema:PublicationIssue
163 N9641e29b68b04b7e843d48ec6e2ee541 rdf:first sg:person.0775516471.70
164 rdf:rest N1d51fa3ac9bc45689091739aaa48db0c
165 N9cfb19bc87964c2eb1a9776aeff57d08 rdf:first Nf2d6031d55e94e4081824cf2037891a4
166 rdf:rest rdf:nil
167 Na566f43bcbe340eba4ddea4421da9361 schema:name Springer Nature - SN SciGraph project
168 rdf:type schema:Organization
169 Nb207b0b52d34458c93b4d73cd0be9099 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Animals
171 rdf:type schema:DefinedTerm
172 Nc108ece2060148f296e3f7c03ede55ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Antibodies, Fungal
174 rdf:type schema:DefinedTerm
175 Nc8b9f5de8d5849a6ab47b4e418d122ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Leukemia
177 rdf:type schema:DefinedTerm
178 Nd877798e291e46bfb3524f1b5a424801 schema:name pubmed_id
179 schema:value 21143834
180 rdf:type schema:PropertyValue
181 Nde32ebbb4e1940f8a86441ec1ef82f78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Candidiasis, Invasive
183 rdf:type schema:DefinedTerm
184 Ndfe574577b8e450b8d9f21376cbb0530 rdf:first sg:person.01272344176.57
185 rdf:rest N2aa17f0b25ef47a397a9d3016938f6c1
186 Nea60d65578ea47738a3a00a96b4afea1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Mannans
188 rdf:type schema:DefinedTerm
189 Nf227e0f896c34c32972904c6817b3e86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Antigens, Fungal
191 rdf:type schema:DefinedTerm
192 Nf2d6031d55e94e4081824cf2037891a4 schema:familyName the Third European Conference on Infections in Leukemia Group
193 rdf:type schema:Person
194 Nffc6728de73f4aef95ca9928f58b5106 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Practice Guidelines as Topic
196 rdf:type schema:DefinedTerm
197 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
198 schema:name Medical and Health Sciences
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
201 schema:name Oncology and Carcinogenesis
202 rdf:type schema:DefinedTerm
203 sg:journal.1117766 schema:issn 1364-8535
204 1466-609X
205 schema:name Critical Care
206 schema:publisher Springer Nature
207 rdf:type schema:Periodical
208 sg:person.01035744051.24 schema:affiliation grid-institutes:grid.7429.8
209 schema:familyName Poulain
210 schema:givenName Daniel
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035744051.24
212 rdf:type schema:Person
213 sg:person.01103701061.44 schema:affiliation grid-institutes:grid.9851.5
214 schema:familyName Calandra
215 schema:givenName Thierry
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103701061.44
217 rdf:type schema:Person
218 sg:person.01241060757.05 schema:affiliation grid-institutes:None
219 schema:familyName Viscoli
220 schema:givenName Claudio
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241060757.05
222 rdf:type schema:Person
223 sg:person.01272344176.57 schema:affiliation grid-institutes:grid.410345.7
224 schema:familyName Mikulska
225 schema:givenName Małgorzata
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272344176.57
227 rdf:type schema:Person
228 sg:person.0775516471.70 schema:affiliation grid-institutes:grid.8142.f
229 schema:familyName Sanguinetti
230 schema:givenName Maurizio
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775516471.70
232 rdf:type schema:Person
233 sg:pub.10.1007/s10096-007-0373-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017843109
234 https://doi.org/10.1007/s10096-007-0373-6
235 rdf:type schema:CreativeWork
236 sg:pub.10.1007/s100960100629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011904460
237 https://doi.org/10.1007/s100960100629
238 rdf:type schema:CreativeWork
239 sg:pub.10.1186/1471-2334-7-103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015191232
240 https://doi.org/10.1186/1471-2334-7-103
241 rdf:type schema:CreativeWork
242 grid-institutes:None schema:alternateName University of Genoa, Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy
243 schema:name University of Genoa, Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy
244 rdf:type schema:Organization
245 grid-institutes:grid.410345.7 schema:alternateName Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy
246 schema:name Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy
247 rdf:type schema:Organization
248 grid-institutes:grid.7429.8 schema:alternateName Unité Inserm U799, Faculté de Médecine, Pôle Recherche, Place Verdun, F-59045, Lille, cedex, France
249 schema:name Unité Inserm U799, Faculté de Médecine, Pôle Recherche, Place Verdun, F-59045, Lille, cedex, France
250 rdf:type schema:Organization
251 grid-institutes:grid.8142.f schema:alternateName Università Cattolica del S. Cuore, Institute Of Microbiology, Largo F. Vito 1, 00168, Rome, Italy
252 schema:name Università Cattolica del S. Cuore, Institute Of Microbiology, Largo F. Vito 1, 00168, Rome, Italy
253 rdf:type schema:Organization
254 grid-institutes:grid.9851.5 schema:alternateName Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland
255 schema:name Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland
256 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...